Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

• Last SEC data release: 2024-10-11
• Last 15 days FTD volume: NZ$0.1 M
• Last 3 months FTD volume: NZ$3.47 M
• Last year FTD volume: NZ$3.47 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Novavax NVAX	NZ$12.75 M	NZ$0.23 B	🇺🇸 USA
BioMarin Pharmaceutical BMRN	NZ$5.84 M	NZ$16.36 M	🇺🇸 USA
Neurocrine Biosciences NBIX	NZ$6.05 M	NZ$29.39 M	🇺🇸 USA
General Electric GE	NZ$0.28 B	NZ$1.28 B	🇺🇸 USA
Thermo Fisher Scientific TMO	NZ$34.32 M	NZ$0.29 B	🇺🇸 USA
Bristol-Myers Squibb BMY	NZ$35.64 M	NZ$0.34 B	🇺🇸 USA
Pfizer PFE	NZ$0.18 B	NZ$0.53 B	🇺🇸 USA
Bio-Techne TECH	NZ$4.08 M	NZ$32.7 M	🇺🇸 USA
Sangamo Therapeutics SGMO	NZ$1.94 M	NZ$2.52 M	🇺🇸 USA
Charles River Laboratories CRL	NZ$32 M	NZ$46.28 M	🇺🇸 USA